Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58,643,980
-
Total 13F shares
-
67,492,943
-
Share change
-
-1,721,967
-
Total reported value
-
$3,609,431,770
-
Put/Call ratio
-
62%
-
Price per share
-
$53.48
-
Number of holders
-
205
-
Value change
-
-$76,258,753
-
Number of buys
-
105
-
Number of sells
-
86
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2020
As of 30 Jun 2020,
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) was held by
205 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,492,943 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., Bellevue Group AG, Capital International Investors, PRICE T ROWE ASSOCIATES INC /MD/, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and ORBIMED ADVISORS LLC.
This page lists
205
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.